stars 1 stars 2 stars 3

At Neurotar, we advance brain research in live mice, offering a more translational alternative to in vitro and ex vivo studies. We provide in vivo two-photon and wide-field imaging of the mouse brain as a service to global pharma and biotech companies focused on the CNS. Our key areas of expertise: • Brain delivery and biodistribution of large molecules • Synaptic plasticity and neuronal activity in health and disease • Neurodegeneration, neuroinflammation, and stroke In vivo two-photon imaging enables longitudinal studies at subcellular resolution, while wide-field imaging captures functional activity across the entire cortex. By imaging awake, head-fixed mice, we avoid anesthesia-related confounds and enhance the relevance of in vivo data. We also develop and commercialize innovative tools for basic research. Our Mobile HomeCage product line supports studies in awake, non-anesthetized mice, eliminating biases linked to anesthesia. The system integrates seamlessly with high-precision techniques like in vivo two-photon imaging, electrophysiology, and optogenetics, combined with behavioral assays. The Mobile HomeCage is trusted by 250+ academic and industrial labs worldwide, especially in North America and Central Europe. CNS drug developers - especially those working on biologics or psychoactive compounds - reach out to learn how Neurotar’s one-of-a-kind imaging assays can sharpen your lead optimization and candidate selection. Neuroscience labs - talk to us if you’re looking for a stable, versatile, and easy-to-use head-fixation solution for mice seamlessly integrated with a behavioral platform via a magnetic locomotion-tracking.

Website http://www.neurotar.com
Revenue $5.7 million
Employees 13 (8 on RocketReach)
Founded 2009
Address 4 Viikinkaari, Helsinki, Uusimaa 00790, FI
Phone +358 9 42834456
Technologies
Industry Research Services, Business Services General, Biotechnology, CNS, Business Services, Science and Engineering, Preclinical, Contract Research, In Vivo, Microscopy, Neuroscience, Drug Screening, Stroke, Neurodegeneration, Migraine, Autoimmune, Blood-Brain Barier, Fluorescence, Research Devices
Web Rank 24 Million
Keywords Brain Research, In Vivo Imaging, Neuroscience Research, Neurological Research, Animal Research, Translational Research, Preclinical Research, Optical Imaging, Drug Discovery, Pharmaceutical Research, Biotechnology Research, Microscopy Services, Research Services, Pharmaceutical Services
Competitors Medtronic, Boston Scientific, Neuronetics, Inc., Cerevel Therapeutics, electroCore, Inc., Nurocor, Inc, CEREBRIU, CureMetrix, NeuroSigma +30 more (view full list)
SIC SIC Code 873 Companies, SIC Code 87 Companies
NAICS NAICS Code 54 Companies, NAICS Code 54171 Companies, NAICS Code 5417 Companies, NAICS Code 541713 Companies, NAICS Code 541 Companies

Neurotar Oy Ltd Questions

The Neurotar Oy Ltd annual revenue was $5.7 million in 2026.

Katja Karelina is the CEO of Neurotar Oy Ltd.

8 people are employed at Neurotar Oy Ltd.

Neurotar Oy Ltd is based in Helsinki, Uusimaa.

The NAICS codes for Neurotar Oy Ltd are [54, 54171, 5417, 541713, 541].

The SIC codes for Neurotar Oy Ltd are [873, 87].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users